Skip to content
Menu
  • News
  • Rugby
  • Old Skool shoes
  • limerick gaa jerseys
  • f1 t shirt
oumea.com

MEPs back new clinical trial rules

Posted on March 6, 2020

MEPs back new clinical trial rules

New rules will require greater transparency.

European Voice

By
Dave Keating

4/2/14, 12:26 PM CET

Updated 5/21/14, 11:42 AM CET

MEPs voted in Brussels today to back a European Commission proposal to increase transparency and harmonisation of Europe’s clinical trials on medicines. MEPs voted 594 to 17 to back a deal reached with member states in December.

Under the new legislation, which will come into effect in 2016, all past and future clinical trials will have to be registered and their results reported. Pharmaceutical companies and academic researchers will have to post the results of all their European clinical trials in a publicly-accessible database.

The new rules will make it easier for these companies and academics to share information about new medicines across borders. Most importantly, the legislation aims to reduce bureaucracy so that clinical trials can be larger, more viable and more reliable.

“The new law will also offer hope to the millions of people in Europe suffering from rare diseases, by making cross-border trials much easier to conduct,” said centre-left British MEP Glenis Willmott, who led negotiations on behalf of the Parliament. “There are simply not enough patients in one country alone to develop new or improved treatments for rare diseases. By working at EU level we can reduce the huge cost and burden of conducting trials across borders.”

Member states agreed to the MEPs’ demand that detailed summaries be published in a publicly-accessible EU database, including full clinical study reports to be published once a decision on marketing authorisation has been taken or the marketing authorisation application has been withdrawn. Fines would be imposed on sponsors who do not comply with these requirements.

In a separate vote, MEPs locked in a first reading position on a proposal to overhaul EU rules on invasive medical devices – those that go inside the human body. Member states remain divided on the controversial subject and have as yet been unable to agree a common position.

With no agreement with member states possible before the end of the parliamentary term, MEPs needed formally to adopt the position agreed in the environment and health committee in September, if they are to bind the next Parliament to work on that basis. MEPs voted 549 to 13 to lock in their position.

Click Here: Cheap Chiefs Rugby Jersey 2019

Authors:
Dave Keating 

Recent Posts

  • Rain Gauge: Measuring Precipitation for Weather and Climate Studies
  • Rain Gauge: A Comprehensive Overview of Its Design and Functionality
  • **How Is Dew Point Calculated**
  • How is Dew Point Calculated?
  • How is Dew Point Calculated?

Recent Comments

    Archives

    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019
    • May 2019
    • April 2019
    • March 2019

    Categories

    • News
    • Rugby

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    ©2025 oumea.com | WordPress Theme by Superbthemes.com